Redox-tuned [18F]4FN radiopharmaceutical is useful for imaging innate immunity activation Feb. 25, 2022
New PET ligand allows in vivo pharmacological evaluation of agents targeting mutant HTT expression Feb. 9, 2022
Navidea sponsors research at Penn to evaluate Tc99m tilmanocept as prognostic marker in glioblastoma Feb. 8, 2022
Indirect radiolabeling of pGlu for intratumoral delivery of alpha- and beta-particle emitters Jan. 10, 2022
TMTP1 peptide dimer probe shows promise for tumor imaging and imaging-guided photothermal therapy Dec. 28, 2021
RSS